Deferred Tax Assets, Valuation Allowance of SpringWorks Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
SpringWorks Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • SpringWorks Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $289,216,000, a 27% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

SpringWorks Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $289,216,000 +$61,997,000 +27% 31 Dec 2024 10-K 20 Feb 2025 2024 FY
Q4 2023 $227,219,000 +$69,393,000 +44% 31 Dec 2023 10-K 20 Feb 2025 2024 FY
Q4 2022 $157,826,000 +$68,594,000 +77% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $89,232,000 +$54,976,000 +160% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $34,256,000 +$16,243,000 +90% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $18,013,000 +$12,640,000 +235% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $5,373,000 31 Dec 2018 10-K 12 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.